Diazepam Tablets

Description

Diazepam Tablets (2mg / 5mg / 10mg)

Manufactured by: Healthy Life Pharma Pvt. Ltd. (WHO-GMP Certified)
Exported by: Healthy Inc (Star Export House)

1. Product Introduction

Healthy Life Pharma Pvt. Ltd. manufactures Diazepam Tablets in India. Diazepam is a long-acting benzodiazepine with anxiolytic, sedative, anticonvulsant and skeletal-muscle-relaxant effects. It is a controlled psychotropic medicine in many jurisdictions and should be manufactured, supplied, prescribed and dispensed in accordance with applicable controlled-substance regulations. Clinical use requires careful assessment because Diazepam can cause sedation, physical dependence, withdrawal reactions and potentially dangerous respiratory depression, especially with opioids, alcohol or other CNS depressants.

2. Product Specifications

3. Manufacturing and Control

• Controlled-Drug Handling: Receipt, storage, dispensing, reconciliation and release of Diazepam are managed under applicable security and controlled-substance requirements.
• Content Uniformity: Validated dispensing, blending and compression processes support consistent low-dose active distribution.
• In-Process Controls: Tablet weight, hardness, friability, disintegration and other critical parameters are monitored according to approved specifications.
• Export Compliance: International supply is subject to destination-country authorization and any required import/export permits, quotas or NOCs.

4. Quality Assurance

• Assay: Diazepam potency is tested using validated analytical methods.
• Content Uniformity: Individual dosage units are tested according to applicable pharmacopoeial/registered acceptance criteria.
• Dissolution: Drug release is verified against the registered finished-product specification.
• Related Substances: Relevant impurities and degradation products are monitored through validated methods and stability studies.

5. Pharmacology and Clinical Uses

Diazepam enhances the inhibitory effect of gamma-aminobutyric acid (GABA) at GABA-A receptors in the central nervous system.

• Anxiety: May be used for short-term relief of severe anxiety symptoms when benzodiazepine treatment is clinically appropriate.
• Alcohol Withdrawal: Can be used under medical supervision for selected acute alcohol-withdrawal symptoms; severe withdrawal may require monitored treatment.
• Muscle Spasm: May be used for selected skeletal muscle-spasm conditions.
• Seizures: Has anticonvulsant activity and may be used in specific seizure-related settings; route and regimen depend on the clinical situation.

6. Export and Regulatory Support

• Dossier Support: CTD / ACTD documentation where applicable.
• Certificates: FSC, COPP and COA where applicable.
• Controlled-Drug Documentation: Supply is subject to applicable psychotropic-drug licenses, import/export permits and destination-country controls.
• Logistics: Authorized shipments can be arranged according to applicable controlled-substance transport and customs requirements.

7. Frequently Asked Questions

Q: Who manufactures Diazepam Tablets?
A: Healthy Life Pharma Pvt. Ltd. manufactures Diazepam tablet formulations in India, subject to applicable licensing and regulatory requirements.

Q: Is Diazepam a controlled medicine?
A: Yes, Diazepam is controlled as a psychotropic/prescription medicine in many countries. Legal classification and supply requirements depend on jurisdiction.

Q: Can Diazepam cause dependence?
A: Yes. Physical dependence can develop, and risk generally increases with dose and duration. Abrupt discontinuation after regular use can cause serious withdrawal reactions, including seizures.

Q: Can Diazepam be combined with alcohol or opioids?
A: Combining benzodiazepines with opioids, alcohol or other CNS depressants can cause profound sedation, respiratory depression, coma or death. Such combinations require explicit medical assessment and should not be self-directed.

Clinical Pharmacology & Safety Information

(For Registered Medical Practitioners & Patient Reference)

8. Dosage and Administration

• Individualized Dosing: Dose and duration depend on indication, age, comorbidities, concomitant medicines and clinical response. Use the lowest effective dose for the shortest appropriate duration according to the registered prescribing information.
• Older / Frail Patients: Greater sensitivity and slower clearance may require lower doses and closer monitoring.
• Withdrawal / Tapering: After regular use, do not stop Diazepam abruptly. A clinician-directed gradual taper may be required to reduce withdrawal risk.
• Administration: Follow the specific product label and prescriber's instructions.

9. Side Effects and Precautions

• Sedation: Drowsiness, fatigue, dizziness, impaired coordination, ataxia and slowed reaction time can occur. Do not drive or operate hazardous machinery until effects are known.
• Dependence & Withdrawal: Misuse, addiction, physical dependence and potentially life-threatening withdrawal reactions can occur.
• Respiratory Depression: Risk is increased by opioids, alcohol, other sedatives, respiratory disease and excessive dosing.
• Falls / Cognitive Effects: Older adults may have increased risk of confusion, falls and fractures.
• Contraindications / Special Risks: Product-specific contraindications may include conditions such as severe respiratory insufficiency, sleep apnea syndrome, myasthenia gravis or severe hepatic impairment; follow the registered label.
• Pregnancy / Breastfeeding: Requires individualized clinician assessment of risks and benefits.

10. Storage Instructions

• Store below 25°C unless otherwise specified on the registered label.
• Keep in a dry place and protect from excessive light and moisture.
• Store securely and keep out of reach of children and unauthorized persons.
• Comply with local controlled-drug storage and record-keeping requirements.